2003
DOI: 10.1016/s0041-1345(03)00696-1
|View full text |Cite
|
Sign up to set email alerts
|

The transplantation donation process in the Centro de Investigaciones Medico Quirurgicas of Cuba: 1999–2002

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…However, our studied case had a personal history of bone marrow transplantation because of chronic myeloid leukaemia and he was on a prednisone regime. Interestingly, leukopenia has also been documented in CMV infections in transplant recipients [16] and it is probable that the presence of this opportunistic virus is associated with the white blood cell picture detected in the patient described here. Therefore, the altered antiviral immune response found in this immunosuppressed individual might be involved in the evolution of the septic complications and fatal outcome.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…However, our studied case had a personal history of bone marrow transplantation because of chronic myeloid leukaemia and he was on a prednisone regime. Interestingly, leukopenia has also been documented in CMV infections in transplant recipients [16] and it is probable that the presence of this opportunistic virus is associated with the white blood cell picture detected in the patient described here. Therefore, the altered antiviral immune response found in this immunosuppressed individual might be involved in the evolution of the septic complications and fatal outcome.…”
Section: Discussionmentioning
confidence: 53%
“…A number of viruses cause increased morbidity and mortality in transplant patients [14][15][16][17]; for example, we recently described the first report of herpes simplex virus and Norwegian scabies in a fatal renal transplant recipient [18]. To protect transplant patients, the American Society of Transplantation (AST) Infectious Diseases Community of Practice and the Transplant Infectious Diseases section of The Transplantation Society (TTS) developed a guidance document for S-OIV in solid organ transplantation recipients [19].…”
Section: Discussionmentioning
confidence: 99%